|
|
|
| Effect of Intravesical Perfusion of Mitomycin after Transurethral Resection of Non-muscle Invasive Bladder Cancer |
| PENG Guang-wei, XIAO Zhong-qun |
| Urological Surgery, Third People's Hospital of Yibin 644000 |
|
|
|
|
Abstract 【Objective】To investigate the effect of intravesical perfusion of mitomycin after transurethral resection of non-muscle invasive bladder cancer (TURBt).【Methods】A total of 86 patients with non-muscle invasive bladder cancer were divided into the control group (43 cases, underwent TURBt ) and the observation group (43 cases, underwent TURBt and combined with mitomycin for bladder infusion). The differences in postoperative recurrence rate, serum tumor related factors, adverse reactions and quality of life were compared between the two groups.【Results】The recurrence rate of the observation group was significantly lower that of the control group (P<0.05). The average recurrence time was significantly longer than that of the control group (P<0.05). The serum levels of VEGF, FGF and MMP-9 in the observation group were significantly lower than those in the control group (P<0.05). The incidence of bladder irritation in the observation group was higher than that in the control group (P<0.05), while the incidence of adverse reactions such as nausea and vomiting, chest tightness and palpitations did not show statistically significant difference (P>0.05). The EORTC QLQ-C30 score and KPS score of the two groups were higher than those before operation (P<0.05), and the two scores in the observation group were significantly higher than those in the control group (P<0.05).【Conclusion】TURBt combined with early mitomycin-induced bladder perfusion therapy on non-muscle infiltration bladder cancer can reduce the recurrence rate, improve the serum levels of tumor related factors without obvious adverse reactions, and improve the quality of life of patients. It is worthy of clinical promotion.
|
|
Received: 04 November 2018
|
|
|
|
|
|
[1] 赵振华, 胡卫列, 郑东升, 等. 羟基喜树碱膀胱灌注化疗联合体外热电场热疗预防浅表性膀胱癌复发的临床研究[J]. 现代泌尿外科杂志, 2014, 19(8):508-512.
[2] 叶丽红. 吡柔比星与丝裂霉素膀胱灌注预防浅表膀胱癌术后复发的疗效比较急护理体会[J]. 海峡医学, 2012, 24(5):178-180.
[3] 薛斌, 何秉勋, 康厚彬, 等. 经尿道膀胱肿瘤电切术联合吡柔比星膀胱灌注治疗对浅表性膀胱癌患者预后及血清相关因子的影响[J]. 实用癌症杂志, 2016, 31(6):1027-1029.
[4] 李金乾, 武跃清, 秦克松, 等. 浅表性膀胱癌经尿道膀胱肿瘤电切术联合丝裂霉素C及干扰素治疗效果与复发原因[J]. 中国临床医生杂志, 2018, 46(1):65-67.
[5] 韩兴涛, 杨锦建, 霍庆祥, 等. 电切术联合吡柔比星膀胱灌注对浅表性膀胱癌疗效[J]. 中国内镜杂志, 2015, 21(5):494-497.
[6] 朱继萍. 丝裂霉素膀胱热灌注治疗浅表性膀胱癌[J]. 中国实用医刊, 2014, 41(21):94-95.
[7] 曹志强, 赵艳华, 杨宏伟, 等. TURBT 术后膀胱灌注 A 群链球菌联合丝裂霉素治疗高危非肌层浸润性膀胱癌的疗效观察[J]. 现代生物医学进展, 2013, 13(30):5913-5915.
[8] 李大鹏. 应用经尿道电切术联合膀胱灌注治疗浅表性膀胱癌的疗效分析[J]. 中国实用医药, 2012, 7 (35): 51-52. |
| [1] |
. [J]. JOURNAL OF CLINICAL RESEARCH, 2019, 36(4): 740-741. |
|
|
|
|
2019, Vol. 36 
